SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Knight who wrote (798)7/19/1998 12:15:00 PM
From: John S. Baker   of 1510
 
<catching up on old messages after returning from vacation>


I wonder if part of the selloff in the face of Dr. Valentine's presentations at Geneva may have been due to general unawareness that different types of "vaccines" exist.


Generally speaking, IMNR's business might be described as "developing a vaccine for AIDS".


But then comes the news, which penetrated the popular media pretty well, saying that (in effect) "a vaccine against AIDS actually *causes* the disease."


For someone who examines the case no more thoroughly than that, IMNR would be a screaming sell.


But my understanding from reading this thread is that REMUNE differs significantly from the vaccine which caused the problems. Am I correct in this?


Disclosure: I am long a modest position in IMNR.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News